Access 2.8M+ Filings Sign Up Free
EUROPEAN GREEN TRANSITION PLC Logo

EUROPEAN GREEN TRANSITION PLC | EGT - Profile, Filings, Stock Info & Investor Relations Data

EUROPEAN GREEN TRANSITION PLC | EGT
Filings & Investor Relations Data
Login to Watchlist

Create a free account or log in.

Industry
Pharmaceuticals
Country
United Kingdom
Founded
N/A
EUROPEAN GREEN TRANSITION PLC (EGT)

Company Profile

About EUROPEAN GREEN TRANSITION PLC

Faron Pharmaceuticals develops innovative immunotherapies, primarily bexmarilimab, targeting the Clever-1 receptor to treat cancer. Our mission is to address unmet medical needs and improve patient lives.

Headquarters

The Walbrook Building
EC4N 8AF, London
United Kingdom

EUROPEAN GREEN TRANSITION PLC (EGT)
Key Financial Data

AI-Powered Financial Insights Coming Soon

We are currently processing the filings for this company to provide automated financial statement analysis, key ratios, and risk summaries. Please check back later!

Unlock Full Company Insights & AI Chat

Create a free account or log in to add companies to your watchlist, access more data, and chat directly with filings using our AI assistant (as shown!).

Create Free Account Sign In

EUROPEAN GREEN TRANSITION PLC (EGT)
Filings & Annual Reports
Chat with AI, summarize, and extract data from processed filings! Look for the 'View & AI' button.

Quick Filters:

Advanced Filters

View all types
Filing Information Actions

Insider Trading Activity

No Insider Trades

There is currently no insider trading data available for this company.

EUROPEAN GREEN TRANSITION PLC (EGT)
Stock & Investor Information

ISINs

GB00BPVG5407

LEI

9845000450IAF4808661

Stock Exchange Listings

London Stock Exchange

Stock Index Memberships

AIM (LSE)

Industry Classification

Sector
Health Care
Industry
Pharmaceuticals